These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25546431)

  • 41. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
    Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
    Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
    J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axillary lymph node treatment in breast cancer: an update.
    Williams PA; Suggs J; Mangana SH
    J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of sentinel lymph node biopsy in early breast cancer.
    Jatoi I
    Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel lymph node biopsy in the management of ductal carcinoma in situ.
    Zujewski J; Eng-Wong J
    Clin Breast Cancer; 2005 Aug; 6(3):216-22. PubMed ID: 16137431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The evolution of regional nodal irradiation in breast cancer.
    Haffty BG; Mahmoud O
    Breast J; 2015; 21(1):32-41. PubMed ID: 25418516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. History of sentinel node and validation of the technique.
    Tanis PJ; Nieweg OE; Valdés Olmos RA; Th Rutgers EJ; Kroon BB
    Breast Cancer Res; 2001; 3(2):109-12. PubMed ID: 11250756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data.
    Charalampoudis P; Markopoulos C; Kovacs T
    Eur J Surg Oncol; 2018 Jan; 44(1):5-14. PubMed ID: 29174281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer.
    Motomura K; Komoike Y; Nagumo S; Kasugai T; Hasegawa Y; Inaji H; Noguchi S; Koyama H
    Breast Cancer; 2002; 9(4):337-43. PubMed ID: 12459716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The historical perspective of the sentinel lymph node concept].
    Bekker J; Meijer S
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):38-45. PubMed ID: 18240761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of the clinically node-negative axilla in primary and locally recurrent breast cancer.
    McGinity AC; Lautner MA; Jatoi I
    Surg Oncol Clin N Am; 2014 Jul; 23(3):463-71. PubMed ID: 24882345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evolution of sentinel lymph node biopsy in breast cancer--axillary staging in the past 15 years at the Uzsoki Street Hospital].
    Mersich T; Faludi S; Ping O; Jóbaházi J; Szabó B; Dede K; Besznyák I; Bursics A
    Magy Seb; 2013 Dec; 66(6):320-4. PubMed ID: 24333976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A few more thoughts regarding the history of the sentinel lymph node in Pécs, Hungary].
    Szilágyi K
    Magy Seb; 2014 Jun; 67(3):139-41. PubMed ID: 24873771
    [No Abstract]   [Full Text] [Related]  

  • 59. The development of lymphatic mapping and selective lymphadenectomy: a historical perspective.
    Wong JH
    Cancer Treat Res; 2005; 127():1-14. PubMed ID: 16209075
    [No Abstract]   [Full Text] [Related]  

  • 60. Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies.
    Manca G; Rubello D; Tardelli E; Giammarile F; Mazzarri S; Boni G; Chondrogiannis S; Marzola MC; Chiacchio S; Ghilli M; Roncella M; Volterrani D; Colletti PM
    Clin Nucl Med; 2016 Feb; 41(2):126-33. PubMed ID: 26447368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.